Second‐line systemic therapy for metastatic colorectal cancer

Background The therapeutic management of people with metastatic colorectal cancer (CRC) who did not respond to first‐line treatment represents a formidable challenge. Objectives To determine the efficacy and toxicity of second‐line systemic therapy in people with metastatic CRC. Search methods We se...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cochrane database of systematic reviews 2017-01, Vol.2017 (1), p.CD006875
Hauptverfasser:	Mocellin, Simone, Baretta, Zora, Roqué i Figuls, Marta, Solà, Ivan, Martin‐Richard, Marta, Hallum, Sara, Bonfill Cosp, Xavier
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant therapy Antineoplastic Agents Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab Bevacizumab - administration & dosage Camptothecin Camptothecin - administration & dosage Camptothecin - analogs & derivatives Camptothecin - therapeutic use Cancer Cancer: colorectal Colorectal Colorectal Neoplasms Colorectal Neoplasms - drug therapy Colorectal Neoplasms - mortality Colorectal Neoplasms - pathology Fluorouracil Fluorouracil - administration & dosage Gastroenterology & hepatology Humans Irinotecan Leucovorin Leucovorin - administration & dosage Medical & adjuvant therapy Medicine General & Introductory Medical Sciences Neoplastic diseases of the colon Neoplastic diseases of the rectum and anus Organoplatinum Compounds Organoplatinum Compounds - administration & dosage Randomized Controlled Trials as Topic Survival Rate Treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!